Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting DOI
Matías A. Ávila, Jean‐François Dufour, Alexander L. Gerbes

и другие.

Gut, Год журнала: 2019, Номер 69(4), С. 764 - 780

Опубликована: Дек. 26, 2019

Alcohol-related liver disease (ALD), which includes a range of disorders different severity and is one the most prevalent types worldwide, has recently regained increased attention. Among other reasons, realisation that any alcohol intake, regardless type beverage represents health risk, new therapeutic strategies tested in published or undergoing clinical trials spur scientific interest this area.In April 2019, Gut convened round table panel experts during European Association for Study Liver International Congress Vienna to discuss critical up-to-date issues trial data regarding ALD, its epidemiology, diagnosis, management, pathomechanisms, possible future treatments prevention. This paper summarises discussion conclusions.

Язык: Английский

The gut-liver axis in liver disease: Pathophysiological basis for therapy DOI Creative Commons
Agustı́n Albillos, Andrea De Gottardi, María Rescigno

и другие.

Journal of Hepatology, Год журнала: 2019, Номер 72(3), С. 558 - 577

Опубликована: Окт. 15, 2019

The gut-liver axis refers to the bidirectional relationship between gut and its microbiota, liver, resulting from integration of signals generated by dietary, genetic environmental factors. This reciprocal interaction is established portal vein which enables transport gut-derived products directly liver feedback route bile antibody secretion intestine. intestinal mucosal vascular barrier functional anatomical structure that serves as a playground for interactions limiting systemic dissemination microbes toxins while allowing nutrients access circulation reach liver. control microbial communities critical maintaining homeostasis axis, part this communication shapes communities. Alcohol disrupts at multiple interconnected levels, including microbiome, mucus barrier, epithelial level antimicrobial peptide production, increases exposure proinflammatory environment Growing evidence indicates pathogenetic role microbe-derived metabolites, such trimethylamine, secondary acids, short-chain fatty acids ethanol, in pathogenesis non-alcoholic disease. Cirrhosis itself associated with profound alterations microbiota damage different levels defence epithelial, immune barriers. relevance severe disturbance cirrhosis has been linked translocation live bacteria, bacterial infections disease progression. identification elements primarily damaged each chronic offers possibilities intervention. Beyond antibiotics, upcoming therapies centred on include new generations probiotics, metabolites (postbiotics), faecal transplantation, carbon nanoparticles. FXR-agonists target both are currently being tested diseases. Finally, synthetic biotic medicines, phages specific bacteria or create physical barriers offer therapeutic approaches.

Язык: Английский

Процитировано

1411

The gut–liver axis and the intersection with the microbiome DOI
Anupriya Tripathi, Justine W. Debelius, David A. Brenner

и другие.

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2018, Номер 15(7), С. 397 - 411

Опубликована: Май 10, 2018

Язык: Английский

Процитировано

1118

C-type lectins in immunity and homeostasis DOI
Gordon D. Brown, Janet A. Willment,

Lauren Whitehead

и другие.

Nature reviews. Immunology, Год журнала: 2018, Номер 18(6), С. 374 - 389

Опубликована: Март 26, 2018

Язык: Английский

Процитировано

598

Alcohol, liver disease and the gut microbiota DOI
Jasmohan S. Bajaj

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2019, Номер 16(4), С. 235 - 246

Опубликована: Янв. 14, 2019

Язык: Английский

Процитировано

558

The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases DOI

Mathias L. Richard,

Harry Sokol

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2019, Номер unknown

Опубликована: Март 1, 2019

Язык: Английский

Процитировано

350

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders DOI Open Access
Daniel M. Chopyk, Arash Grakoui

Gastroenterology, Год журнала: 2020, Номер 159(3), С. 849 - 863

Опубликована: Июнь 20, 2020

Язык: Английский

Процитировано

320

Gut microbiome, liver immunology, and liver diseases DOI Open Access
Rui Wang, Ruqi Tang, Bo Li

и другие.

Cellular and Molecular Immunology, Год журнала: 2020, Номер 18(1), С. 4 - 17

Опубликована: Дек. 14, 2020

Язык: Английский

Процитировано

303

Inflammatory pathways in alcoholic steatohepatitis DOI Open Access
Bin Gao, Maleeha Ahmad, Laura E. Nagy

и другие.

Journal of Hepatology, Год журнала: 2019, Номер 70(2), С. 249 - 259

Опубликована: Янв. 15, 2019

Язык: Английский

Процитировано

296

Commensal Fungi in Health and Disease DOI Creative Commons
Jose J. Limon, Joseph H. Skalski, David M. Underhill

и другие.

Cell Host & Microbe, Год журнала: 2017, Номер 22(2), С. 156 - 165

Опубликована: Авг. 1, 2017

Язык: Английский

Процитировано

288

Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice DOI
Tim Hendrikx, Yi Duan, Yanhan Wang

и другие.

Gut, Год журнала: 2018, Номер 68(8), С. 1504 - 1515

Опубликована: Ноя. 17, 2018

Antimicrobial C-type lectin regenerating islet-derived 3 gamma (REG3G) is suppressed in the small intestine during chronic ethanol feeding. Our aim was to determine mechanism that underlies REG3G suppression experimental alcoholic liver disease.Interleukin 22 (IL-22) regulates expression of REG3G. Therefore, we investigated role IL-22 mice subjected chronic-binge feeding (NIAAA model).In a mouse model disease, found type innate lymphoid cells produce lower levels IL-22. Reduced production result ethanol-induced dysbiosis and intestinal indole-3-acetic acid (IAA), microbiota-derived ligand aryl hydrocarbon receptor (AHR), which Importantly, faecal IAA were also be patients with hepatitis compared healthy controls. Supplementation restore protected from steatohepatitis by inducing REG3G, prevented translocation bacteria liver. We engineered Lactobacillus reuteri (L. reuteri/IL-22) fed them along diet; these had reduced damage, inflammation bacterial an isogenic control strain upregulated intestine. However, L. reuteri/IL-22 did not reduce disease Reg3g-/- mice.Ethanol-associated reduces activation AHR decrease intestine, leading REG3G; this results steatohepatitis. Bacteria induce

Язык: Английский

Процитировано

275